Ista’s T-Pred “Not Approvable” For Inflammatory Eye Conditions
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm may have to conduct additional clinical trials for the fixed-dose antibiotic/steroid combination, Chief Financial Officer tells “The Pink Sheet” DAILY.